one small retrospective study and ongoing phase 2 trial in China
If you experience serious side effects, such as allergic reactions, low blood sugar levels, or severe gastrointestinal issues, do not take the next dosage of semaglutide before consulting your healthcare provider
Many patients successfully use these medications without any lab testing
Worse yet, a 2024 study suggests that TB-500 itself may not even be the active compound, but that its healing activity might come from a smaller piece it breaks down into in the body
GLP-1 RAs, including oral semaglutide, offer promising solutions due to their effectiveness in glycemic control, weight management, and cardiorenal protection compared to DPP-4 inhibitors and many SGLT2 inhibitors